Determining Clinical Thresholds for Donor HLA Eplet Compatibility to Predict Best Outcomes Following Lung Transplantation.

Hiho, Steven J; Walton, Duncan C; Paraskeva, Miranda A; Levvey, Bronwyn J; Diviney, Mary B; Snell, Gregory I; Sullivan, Lucy C; Westall, Glen P

Hiho, Steven J; Walton, Duncan C; Paraskeva, Miranda A; Levvey, Bronwyn J; Diviney, Mary B; Snell, Gregory I; Sullivan, Lucy C; Westall, Glen P.

Afiliação

Hiho SJ; Lung Transplant Service, Department of Respiratory Medicine, Alfred Hospital and Monash University, Melbourne, VIC, Australia.
Walton DC; Australian Red Cross LifeBlood, Victorian Transplantation and Immunogenetics Service, Melbourne, VIC, Australia.
Paraskeva MA; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Levvey BJ; Lung Transplant Service, Department of Respiratory Medicine, Alfred Hospital and Monash University, Melbourne, VIC, Australia.
Diviney MB; Lung Transplant Service, Department of Respiratory Medicine, Alfred Hospital and Monash University, Melbourne, VIC, Australia.
Snell GI; Australian Red Cross LifeBlood, Victorian Transplantation and Immunogenetics Service, Melbourne, VIC, Australia.
Sullivan LC; Lung Transplant Service, Department of Respiratory Medicine, Alfred Hospital and Monash University, Melbourne, VIC, Australia.
Westall GP; Lung Transplant Service, Department of Respiratory Medicine, Alfred Hospital and Monash University, Melbourne, VIC, Australia.

Transplant Direct ; 8(10): e1364, 2022 Oct.

Article em En | MEDLINE | ID: mdl-36204183

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google